198 related articles for article (PubMed ID: 32011514)
1. Myopathy after rapid correction of hyperthyroidism: A case report and review of literature.
Lu R; Wang H; Hong T; Gao H
Medicine (Baltimore); 2020 Jan; 99(3):e18878. PubMed ID: 32011514
[TBL] [Abstract][Full Text] [Related]
2. Myopathy Associated with Treatment of Graves' Disease.
Ji YK; Kim SH
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684053
[TBL] [Abstract][Full Text] [Related]
3. Myopathy in hyperthyroidism as a consequence of rapid reduction of thyroid hormone: A case report.
Li Q; Liu Y; Zhang Q; Tian H; Li J; Li S
Medicine (Baltimore); 2017 Jul; 96(30):e7591. PubMed ID: 28746208
[TBL] [Abstract][Full Text] [Related]
4. Elevation of serum creatine kinase induced by anti-thyroid drugs: Two case reports and a literature review.
Si Y; Su F; Wu H; Shen C
Int J Clin Pharmacol Ther; 2022 Nov; 60(11):492-498. PubMed ID: 36052652
[TBL] [Abstract][Full Text] [Related]
5. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
6. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs.
Suzuki S; Ichikawa K; Nagai M; Mikoshiba M; Mori J; Kaneko A; Sekine R; Asanuma N; Hara M; Nishii Y; Yamauchi K; Aizawa T; Hashizume K
Arch Intern Med; 1997 Mar; 157(6):693-6. PubMed ID: 9080924
[TBL] [Abstract][Full Text] [Related]
7. Elevation of serum creatine kinase during methimazole treatment of Graves disease in a 13-year-old girl and a literature review of similar cases.
Kim H; Kim J; Huh R; Cho SY; Jin DK
Ann Pediatr Endocrinol Metab; 2015 Jun; 20(2):106-9. PubMed ID: 26191516
[TBL] [Abstract][Full Text] [Related]
8. Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.
Leo M; Bartalena L; Rotondo Dottore G; Piantanida E; Premoli P; Ionni I; Di Cera M; Masiello E; Sassi L; Tanda ML; Latrofa F; Vitti P; Marcocci C; Marinò M
J Endocrinol Invest; 2017 Mar; 40(3):281-287. PubMed ID: 27734319
[TBL] [Abstract][Full Text] [Related]
9. An unusual evolution of thyroid function after therapeutic plasma exchange in Graves' disease with cholestatic jaundice: A case report.
Jin Y; Feng X; Ni H
Medicine (Baltimore); 2024 Feb; 103(8):e37074. PubMed ID: 38394504
[TBL] [Abstract][Full Text] [Related]
10. Cross-sectional investigation of serum creatine kinase concentration in Graves disease patients treated with oral antithyroid drugs.
Cheng Y; Sun Z; Zhong D; Ren L; Yang H
Medicine (Baltimore); 2020 Oct; 99(43):e22898. PubMed ID: 33120839
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
[TBL] [Abstract][Full Text] [Related]
12. THERAPEUTIC EFFECTS OF COMBINATION REGIMENS INCLUDING METHIMAZOLE ON GRAVES HYPERTHYROIDISM: A NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
Wang M; Yu Y
Endocr Pract; 2020 Jun; 26(6):675-687. PubMed ID: 32160045
[No Abstract] [Full Text] [Related]
13. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
15. Elevation of serum creatine kinase in response to medical treatment of Graves' disease in children.
Mizuno H; Sugiyama Y; Nishi Y; Ueda N; Ohro Y; Togari H
Acta Paediatr; 2006 Feb; 95(2):243-5. PubMed ID: 16449033
[TBL] [Abstract][Full Text] [Related]
16. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
[TBL] [Abstract][Full Text] [Related]
17. Control of Graves' hyperthyroidism with very long-term methimazole treatment: a clinical trial.
Azizi F; Abdi H; Amouzegar A
BMC Endocr Disord; 2021 Jan; 21(1):16. PubMed ID: 33446181
[TBL] [Abstract][Full Text] [Related]
18. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
[TBL] [Abstract][Full Text] [Related]
19. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations and early effectiveness of methimazole in patients with graves' hyperthyroidism-related severe hepatic dysfunction.
Li C; Wang KL; Hu JH; Su HB
Scand J Gastroenterol; 2023; 58(12):1514-1522. PubMed ID: 37545358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
